Cargando…

Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials

OBJECTIVE: Clinical trials are increasingly globalized, and adverse event (AE) rates and treatment responses may differ by geographical region. This study assessed regional differences in AE reporting rates and ACR response rates (ACR20/50) in patients with RA who received placebo/standard-of-care t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keebler, Daniel, Teng, Edmond, Chia, Jenny, Galanter, Joshua, Peake, Jodie, Tuckwell, Katie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516100/ https://www.ncbi.nlm.nih.gov/pubmed/32182362 http://dx.doi.org/10.1093/rheumatology/keaa043

Ejemplares similares

Placebo-Related Adverse Events in Rheumatoid Arthritis
por: Sharma, Ratna Shree, et al.
Publicado: (2022)

Simultaneous Exposure–Response Modeling of ACR20, ACR50, and ACR70 Improvement Scores in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol
por: Lacroix, B D, et al.
Publicado: (2014)

Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
por: Gale, Sara, et al.
Publicado: (2019)

The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register
por: Humphreys, Jennifer H, et al.
Publicado: (2013)

The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria
por: van de Sande, Marleen G. H., et al.
Publicado: (2012)

Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis
por: Welsh, Paul, et al.
Publicado: (2016)

Misdiagnosis of Rheumatoid Arthritis in a Long-Term Cohort of Early Arthritis Based on the ACR-1987 Classification Criteria
por: Leu Agelii, Monica, et al.
Publicado: (2022)

Validation of ACR/EULAR definition of remission in rheumatoid arthritis from RA practice: the ESPOIR cohort
por: Zhang, Bin, et al.
Publicado: (2012)

The Role of Bone Scintigraphy in the Diagnosis of Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria
por: Kim, Ji Young, et al.
Publicado: (2014)

Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in routine clinical care
por: Kennish, Lauren, et al.
Publicado: (2012)

Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH)
por: Alves, Celina, et al.
Publicado: (2011)

Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression
por: Bosello, Silvia, et al.
Publicado: (2011)

Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study
por: Lee, Yvonne C, et al.
Publicado: (2011)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016)

Response to 'Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study'
por: Yoshida, Kazuki, et al.
Publicado: (2011)

Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials
por: Strand, Vibeke, et al.
Publicado: (2017)

Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis
por: Chan, Phyllis, et al.
Publicado: (2020)

Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid Arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2016)

Adverse effects of rheumatoid arthritis on bone remodeling
por: Goldring, SR, et al.
Publicado: (2004)

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
por: Paulshus Sundlisæter, Nina, et al.
Publicado: (2022)

Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry
por: Tesser, John, et al.
Publicado: (2022)

Clinical Image Evaluation of Film Mammograms in Korea: Comparison with the ACR Standard
por: Gwak, Yeon Joo, et al.
Publicado: (2013)

Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis
por: Haas, Julia W., et al.
Publicado: (2022)

Expression of acrA and acrB Genes in Esherichia coli Mutants with or without marR or acrR Mutations
por: Pourahmad Jaktaji, Razieh, et al.
Publicado: (2013)

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
por: Dikranian, Ara, et al.
Publicado: (2021)

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
por: Winthrop, Kevin L., et al.
Publicado: (2022)

Laboratory Standards in Diagnosis and Therapy Monitoring of Rheumatoid Arthritis
por: Tešija-Kuna, Andrea
Publicado: (2006)

Structural basis for inhibition of the type I-F CRISPR–Cas surveillance complex by AcrIF4, AcrIF7 and AcrIF14
por: Gabel, Clinton, et al.
Publicado: (2020)

The Rheumatoid Arthritis and MUScle (RAMUS) Study: Protocol for an observational single-arm study of skeletal muscle in patients with rheumatoid arthritis receiving tofacitinib
por: Bennett, Joshua L., et al.
Publicado: (2023)

Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets
por: de Launay, Daphne, et al.
Publicado: (2011)

Revisiting the disabilities of the arm, shoulder and hand (DASH) and QuickDASH in rheumatoid arthritis
por: Prodinger, B., et al.
Publicado: (2019)

Predictors of fatigue in rheumatoid arthritis
por: Druce, Katie L, et al.
Publicado: (2019)

Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis
por: Wei, Kai, et al.
Publicado: (2022)

Adverse effects of maternal rheumatoid arthritis during pregnancy on children
por: Li, Rong, et al.
Publicado: (2021)

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis
por: Guiot, Julien, et al.
Publicado: (2023)

Acre : the rise and fall of a Palestinian city, 1730-1831 /
por: Philipp, Thomas, 1941-
Publicado: (2001)

Interchangeability of periplasmic adaptor proteins AcrA and AcrE in forming functional efflux pumps with AcrD in Salmonella enterica serovar Typhimurium
por: Alav, Ilyas, et al.
Publicado: (2021)

Predictors of chronicity and the discriminative value of the new ACR/EULAR rheumatoid arthritis classification criteria in an untreated polyarthritis cohort with less than 6 weeks of disease duration
por: Mourão, A F, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6kvldur8g7iolo021prje9vma6